Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector Sarclisa Escena ...

By Foo Yun Chee and Inti Landauro BRUSSELS, July 8 (Reuters) - French pharmaceutical company Sanofi has offered to state ...

Sanofi has scored FDA approval for its subcutaneous version of Sarclisa, giving the multiple myeloma treatment a potential ...

By Sneha S K and Bhanvi Satija July 10 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved a ...

The comment-seeking period and probe tie back to Sanofi’s marketing for its flu shot for adults ages 60 and over, which is ...

Sanofi (SNY) wins FDA approval for Sarclisa Escena, a subcutaneously-delivered version of its multiple myeloma therapy ...

In the Baby-COMET trial, Nexviazyme met all primary and secondary endpoints, teeing it up for potential label expansion.

The commission said it was concerned the company’s campaign to promote its Efluelda flu vaccine might amount to ...

Sanofi appoints Paulo Fontoura as Global Head of R&DParis, June 22, 2026. Sanofi today announced the appointment of Paulo Fontoura, MD, PhD, ...

State grant funding will help companies across the state lower emissions. One of those projects awarded is in Monroe County ...

View Sanofi SA Sponsored ADR SNY stock quote prices, financial information, real-time forecasts, and company news from CNN.

Sanofi SA is under investigation by European Commission watchdogs over suspicions it illegally disparaged a rival flu vaccine to boost its own profits.